Cannabis Law Report | How to buy Skittles Moonrock online

Mount Sinai Health System, located at 112th Street & Broadway, opened the Parsons Research Center For Psychedelic healing on Wednesday. Bob and Renee Parson attended the ribbon-cutting, as did Sen. Krysten S. Sinema, I-Ariz., and Rep. Jack Bergman, R-Mich., whose foundation contributed $5 million to the center.

The center is currently conducting research on MDMA-assisted treatment for suicidality among veterans and ketamine therapy for patients with major depression disorder. The new psychedelic healing center, according to Rachel Yehuda the director of the center, aims to give those suffering from post-traumatic disorder more treatment options.

The team moved into Morningside Heights because of its proximity to Mount Sinai Morningside Hospital. They hope to develop a relationship with the community in the near future. Amy Lehrner is the center’s Associate Director. She says that while the majority of the work is focused on veterans, the center also wants to provide trauma treatment to the community.

“The surrounding community is in need of trauma and PTSD,” Lehrner stated. “We will be reaching out to the local community and recruiting from them down the road.”

The research center recruits participants through the James J. Peters Department of Veterans Affairs Medical Center located in the Bronx, as well as community outreach in East Harlem. According to Dr. Lauren Lepow (CC ’13), assistant professor of psychiatry and psychiatry in the Icahn School of Medicine, Mount Sinai, many participants also self-refer.

Lepow said that each patient received individualized attention during the trial. After a thorough screening process that takes into account the patient’s medical history and social background, they meet over several sessions with two therapists.

“First and foremost, we really try to establish the trust. Lepow said, “This person is going do something so vulnerable.”

After the screening, two therapists will sit with the patient and administer the medication for eight hours. Integration, a crucial part of healing, begins the day after the screening process. The therapists ask the patients to share their experience and help them set realistic healing expectations. Lepow said, “This is just the beginning of the journey. It’s not the end.”

Tamar Glatman Zaretsky is a clinical psychologist, study therapist and a clinical psychologist. She echoed the importance of providing new treatments to patients, particularly those with conditions such as PTSD that can cause difficulty in accessing emotions. Zaretsky suggested that psychedelics may help patients to access their emotions. She also noted that opinions on psychedelic therapies remain mixed.